Eledon Pharmaceuticals (ELDN) EPS (Weighted Average and Diluted) (2021 - 2026)
Eledon Pharmaceuticals posted quarterly EPS (Weighted Average and Diluted) of -$0.33 for Q1 2026, down 312.5% year-on-year from $0.16 in Q1 2025, and down 174.56% on a QoQ basis from -$0.12 in Q4 2025.
Eledon Pharmaceuticals (ELDN) has 6 years of EPS (Weighted Average and Diluted) data on file, last reported at -$0.33 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Weighted Average and Diluted) fell 312.5% year-over-year to -$0.33; the trailing twelve-month figure through Mar 2026 stood at -$0.75 (up 98.53% YoY), and the FY2025 full-year result was -$0.52, up 31.04% from the prior year.
- EPS (Weighted Average and Diluted) for Q1 2026 stood at -$0.33, down from -$0.12 in the prior quarter.
- Across five years, EPS (Weighted Average and Diluted) topped out at $0.48 in Q4 2024 and bottomed at -$51.29 in Q2 2024.
- The 5-year median for EPS (Weighted Average and Diluted) is -$0.65 (2022), against an average of -$3.74.
- Peak annual rise in EPS (Weighted Average and Diluted) reached 151.06% in 2024, while the deepest fall reached 1771.9% in 2024.
- A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$4.09 in 2022, then soared by 77.02% to -$0.94 in 2023, then jumped by 151.06% to $0.48 in 2024, then sank by 125.04% to -$0.12 in 2025, then tumbled by 174.56% to -$0.33 in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at -$0.33 (Q1 2026), -$0.12 (Q4 2025), and -$0.21 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -4.43 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 3,086.42 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 0.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 4.02 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 6.75 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.51 |
| 10 | Eledon Pharmaceuticals | 419.90 Mn | 203.87 Mn | - | -0.33 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.33 |
| Dec 31, 2025 | -0.12 |
| Sep 30, 2025 | -0.21 |
| Jun 30, 2025 | -0.13 |
| Mar 31, 2025 | -0.08 |
| Dec 31, 2024 | 0.48 |
| Sep 30, 2024 | -0.28 |
| Jun 30, 2024 | -51.29 |
| Mar 31, 2024 | -0.65 |
| Dec 31, 2023 | -0.94 |
| Sep 30, 2023 | -0.33 |
| Jun 30, 2023 | -2.74 |
| Mar 31, 2023 | -0.75 |
| Dec 31, 2022 | -4.09 |
| Sep 30, 2022 | -0.73 |
| Jun 30, 2022 | -0.65 |
| Mar 31, 2022 | -0.69 |
| Dec 31, 2021 | -0.60 |
| Sep 30, 2021 | -0.66 |
| Jun 30, 2021 | -0.50 |